Recent reports also hypothesized that GRN gene variants could be ALS phenotypic modifiers [66] and that senataxin (SETX), the genetic cause of ALS type 4 (ALS4), could be a modifier of C9orf72 pathology. This evidence concerns the gene SETX and amyotrophic lateral sclerosis type 4.